Orthopedic & Muscular System: Current Research
Open Access

Primary bone lymphoma of the humerus about a case and literature review

Olivia Williams^{* *}Correspondence: Olivia Williams, Department of Science, University of Barcelona, Barcelona, Spain, Email:

Author info »

Editorial

Primary localised bone lymphoma is a rare disease that affects people. It is more common in long bones; however, it can be found in every skeletal bone. Anatomopathological and immunohistochemical studies of a bone biopsy are used to make the diagnosis. Chemotherapy (with or without anti-CD20) is used first, followed by radiation.

Primary localized bone lymphoma has a fairly good prognosis. We also describe the first case of primary bone lymphoma of the humerus diagnosed since our university hospital opened. Primary bone lymphoma was described by the World Health Organization (WHO) in 2002 as a single bone lesion with or without regional lymph node involvement or multiple bone lesions without distant visceral or lymph node involvement. Primary bone lymphomas account for 1% to 3% of nonlymphomas, Hodgkin's 5% of extra-ganglionic non-lymphomas, Hodgkin's and 3% of primary bone tumours.

The primary location of a malignant lymphoma in the bone is characterized as a primary bone lymphoma, with a negative extension assessment within 6 months of the positive diagnosis. Unique bone localization is another requirement for inclusion, but some writers classify multifocal bone lymphomas as primary bone lymphomas. Primary bone lymphomas are quite uncommon. They are more common in men between the ages of 40 and 60.

Primary bone lymphomas that are localized have a fairly excellent prognosis. After 5 years, the survival probability at stage I is 90%. The International Publication Institute (IPI) is a nonprofit organization. The international prognosis index is a metric that measures how well people are doing (age, general health, stage, etc.) The number of lymph node areas affected by LDH) is a measure of the disease's severity. independent predictor of overall survival in patients. A kind of cancer that affects the bones is primary bone lymphoma.

Localized primary bone lymphomas have a very good prognosis. At stage I, the survival probability is 90% after 5 years. The IPI (International Publication Institute) is a non-profit international prognosis index (age, general health, stage, etc.). The number of lymph node regions impacted by LDH) is an indicator of the severity of the condition. Independent predictive factor for patients' overall survival. Primary bone lymphoma is a type of cancer that affects the bones. The Ann Arbor classification system is used to classify primary bone lymphoma into four phases. Humans are affected by primary localized bone lymphoma, which is a rare disease. It is more common in long bones; however it can be found in every skeletal bone. The clinical picture isn't very specific. Anatomopathological and immunohistochemical studies of a bone biopsy are used to make the diagnosis. Chemotherapy (with or without anti-CD20) is used first, followed by radiation. Primary localized bone lymphoma has a fairly good prognosis.